Exhibit 10.1

LOGO [g40981img001.jpg]

April 18, 2008

Steven P. Alsene

13520 Sunset Lakes Circle

Winter Garden, Florida 34787

 

  Re: Amendment to Agreement with Respect to Rights Upon Termination of
Employment (“Amendment”)

Dear Steve:

Reference is made to the Agreement with Respect to Rights Upon Termination of
Employment between Steven P. Alsene (“Executive”) and Rotech Healthcare Inc.
(“the Company”) dated November 8, 2006, (“Employment Letter”). All defined terms
used without definitions shall have the meanings provided in the Employment
Letter.

WHEREAS, Executive is currently employed as the Chief Financial Officer of the
Company;

WHEREAS, the Board of Directors of the Company believes that it is in the best
interest of the Company to provide additional financial incentives to the
Executive in connection with the Executive’s continued employment with the
Company as its Chief Financial Officer;

NOW, THEREFORE, for good and valuable consideration, the receipt of which is
hereby acknowledged, the Company and the Executive hereby agree to amend the
Employment Letter as follows:

1. The Employment Letter is hereby amended to add a new Paragraph to read as
follows:

“Additional Financial Incentives: In addition to the Base Salary and annual
incentive target bonus provided to the Executive, the Executive shall be
entitled to receive the following compensation:

(a) for so long as the Company remains in compliance with the provisions of
Sections 7.01, 7.02 and 7.03 of the Credit Agreement, dated as of March 30,
2007, among the Company, Credit Suisse, as Administrative Agent and Collateral
Agent, and the other lenders parties thereto and the provisions of Sections
4.07, 4.08 and 4.09 of the Indenture, dated as of March 26, 2002 between the
Company and the Bank of New York, as Trustee, the Company shall pay to the
Executive an amount equal to Twelve Thousand Nine Hundred Sixteen Dollars
($12,916) on the tenth (10th) day of each of the six consecutive months
commencing on April 10, 2008.

2600 Technology Drive • Suite 300 • Orlando, FL 32804 • (407) 822-4600

--------------------------------------------------------------------------------

LOGO [g40981img001.jpg]

(b) In addition to the amounts provided for in Paragraph (a) above, unless
directed otherwise by the Chief Executive Officer of the Company in his complete
and sole discretion, the Company shall pay to the Executive an amount equal to
Twelve Thousand Nine Hundred Sixteen Dollars ($12,916) at the same times and for
the same six consecutive months for which payments are provided for under
Paragraph (a) above.

(c) If, based upon any certificate or other report made by the Company, the
Company is not in compliance with the provisions of the Credit Agreement or the
Indenture referred to above, the payments provided for in Paragraph (a) above
shall immediately cease and any amount received by the Executive pursuant to
Paragraph (a) above in respect of any month during which the Company was not in
compliance shall be set off against amounts payable under the new paragraph
referenced above in this Amendment.”

2. The Employment Letter is hereby amended to add a second new Paragraph to read
as follows:

“Change of Control Payment.

In the event of the closing of a Change of Control (as the term is defined
below), the Company shall pay to Employee in a lump sum concurrent with such
closing, an amount equal to the sum of (a) 100% of Employee’s annual base salary
(measured as of the time of the closing of the Change of Control transaction),
and (b) 100% of Employee’s annual target performance bonus for the year in which
the closing of the Change of Control transaction occurs. For purposes of this
4th Amendment, a “Change of Control” shall be deemed to have occurred if, after
the signing of the 4th Amendment, there shall have occurred any of the
following: (i) any “person,” as such term is used in Section 13(d) and 14(d) of
the Securities Exchange Act of 1934 (the “Exchange Act”), other than the
Company, any trustee or other fiduciary holding securities under an employee
benefit plan of the Company or a Group Affiliate, or any company owned, directly
or indirectly, by the shareholders of the Company in substantially the same
proportions as their ownership of stock of the Company, acquires beneficial
ownership (as defined under Section 13(d) of the Exchange Act) of voting
securities of the Company and immediately thereafter is a “50% Beneficial
Owner.” For purposes of this provision, a “50% Beneficial Owner” shall mean a
person who is the “beneficial owner” (as defined under Section 13(d) of the
Exchange Act), directly or indirectly, of securities of the Company representing
more than 50% of the combined voting power of the Company’s then-outstanding
voting securities; provided, however, that the term “50% Beneficial Owner” shall
not include any person who was a beneficial owner of outstanding voting
securities of the Company at the time of the signing of the 4th Amendment (an
“Existing Shareholder”), including any group that may be formed which is
comprised solely of Existing Shareholders or any affiliate of an Existing
Shareholder to whom voting securities may be transferred if and for so long as
the Existing

2600 Technology Drive • Suite 300 • Orlando, FL 32804 • (407) 822-4600

--------------------------------------------------------------------------------

LOGO [g40981img001.jpg]

Shareholder remains an indirect beneficial owner of the voting securities
following such transfer, unless and until such time after the signing of the 4th
Amendment any such Existing Shareholder shall have acquired beneficial ownership
(other than by means of a stock dividend, stock split, gift, inheritance or
receipt of securities in compensation for individual services as a director or
officer of the Company) of any additional voting securities of the Company;
(ii) during any period of two (2) consecutive years commencing on or after the
signing of the 4th Amendment, individuals who at the beginning of such period
constitute the Board, and any new director (other than a director designated by
a “person” (as defined above) who has entered into an agreement with the Company
to effect a transaction described in subsections (i), (iii) or (iv) of this
definition) whose election by the Board or nomination for election by the
Company’s shareholders was approved by a vote of at least two-thirds (2/3) of
the directors then still in office who either were directors at the beginning of
the period or whose election or nomination for election was previously so
approved (the “Continuing Directors”), cease for any reason to constitute at
least a majority thereof; (iii) the shareholders of the Company have approved a
merger, consolidation, recapitalization, or reorganization of the Company, or a
reverse stock split of any class of voting securities of the Company, or the
consummation of any such transaction if shareholder approval is not obtained,
other than any such transaction which would result in at least 50% of the
combined voting power of the voting securities of the Company or the surviving
entity outstanding immediately after such transaction being beneficially owned
by persons who together beneficially owned at least 80% of the combined voting
power of the voting securities of the Company outstanding immediately prior to
such transaction with the relative voting power of each such continuing holder
compared to the voting power of each other continuing holder not substantially
altered as a result of the transaction; provided that, for purposes of this
Section (iii), such continuity of ownership (and preservation of relative voting
power) shall be deemed to be satisfied if the failure to meet such 50% threshold
(or to substantially preserve such relative voting power) is due solely to the
acquisition of voting securities by an employee benefit plan of the Company or
Group Affiliate, such surviving entity or a subsidiary thereof; and provided
further, that, if consummation of the corporate transaction referred to in this
Section (iii) is subject, at the time of such approval by shareholders, to the
consent of any government or governmental agency or approval of the shareholders
of another entity or other material contingency, no Change of Control shall
occur until such time as such consent and approval has been obtained and any
other material contingency has been satisfied; or (iv) the shareholders of the
Company have approved a plan of complete liquidation of the Company or an
agreement for the sale or disposition by the Company of all or substantially all
of the Company’s assets (or any transaction having a similar effect); provided
that, if consummation of the transaction referred to in this Section (iv) is
subject, at the time of such approval by shareholders, to the consent of any
government or governmental agency or approval of the shareholders of another
entity or other material contingency, no Change of Control shall occur until
such time as such consent and approval has been obtained and any other material
contingency has been satisfied.

2600 Technology Drive • Suite 300 • Orlando, FL 32804 • (407) 822-4600

--------------------------------------------------------------------------------

LOGO [g40981img001.jpg]

The foregoing notwithstanding, a transaction shall not constitute a Change of
Control if its sole purpose is to change the state of the Company’s
incorporation. In addition, an initial public offering (“IPO”) of the securities
of the Company shall not constitute a Change of Control for purposes of this
Agreement.”

4. Except as set forth in this Amendment, all of the terms of the Employment
Letter shall remain in full force and effect.

IN WITNESS WHEREOF, the Company and the Executive have executed this Amendment
as of the date first written above.

 

Very truly yours,

 

Rotech Healthcare Inc.

 

By:  

 

Name:   Philip L. Carter Title:   Chief Executive Officer & President

 

Accepted and Agreed:

 

 

Steven P. Alsene

2600 Technology Drive • Suite 300 • Orlando, FL 32804 • (407) 822-4600